Curcumin — Stack & Timing
Educational timing and stacking information based on how Curcumin has been studied. Not a prescription. Not medical advice.
This is educational information only. Consult a healthcare provider before starting any supplement.
Stack & Timing Guidance
Educational summary based on how Curcumin has been studied and commonly used.
Commonly studied timing
Curcumin is fat-soluble, so taking it with a meal containing dietary fat significantly improves absorption; timing across morning or evening is generally flexible, though post-workout use has been studied in the context of exercise-induced inflammation and recovery.
Dose ranges used in studies
Clinical trials have commonly studied doses in the 500–1000 mg/day range using bioavailability-enhanced formulations (e.g., with piperine, phospholipid complexes, or nanoparticle delivery), as standard curcumin has very poor oral bioavailability; some studies have used higher doses up to 1500–2000 mg/day, particularly for metabolic or inflammatory outcomes.
↑ These are ranges from research studies, not personal dosing recommendations. Discuss with a clinician.
Commonly paired with
Piperine inhibits hepatic and intestinal glucuronidation, substantially increasing curcumin bioavailability — co-supplementation studies suggest up to ~20-fold improvement in plasma curcumin levels
Both compounds have complementary anti-inflammatory mechanisms; combined use has been studied for osteoarthritis and joint pain, with some evidence of additive or synergistic effects on pain and function
Both exert anti-inflammatory effects via distinct pathways (curcumin via NF-κB inhibition; omega-3s via eicosanoid modulation); fat content of fish oil may also aid curcumin absorption
Both are fat-soluble compounds with overlapping roles in immune modulation and inflammation; co-administration with a fat-containing meal can support absorption of both simultaneously
Safety & interactions
Curcumin is generally well-tolerated at studied doses; high doses may cause gastrointestinal discomfort (nausea, diarrhea) in some individuals. Piperine co-administration, while improving bioavailability, may itself affect drug metabolism. Long-term safety at very high doses is not fully established.
- •Anticoagulants and antiplatelet drugs (e.g., warfarin, aspirin, clopidogrel): curcumin may have additive blood-thinning effects, potentially increasing bleeding risk
- •Cytochrome P450 substrates: curcumin can inhibit CYP3A4 and CYP2C9 enzymes, potentially altering metabolism of certain medications
- •Piperine co-administration may further affect drug bioavailability by inhibiting drug-metabolizing enzymes and transporters
- •Diabetes medications: curcumin may have additive glucose-lowering effects, potentially requiring dose adjustments
Individuals with gallbladder disease or bile duct obstruction should avoid high-dose curcumin, as it stimulates bile secretion. Those scheduled for surgery should discontinue use due to antiplatelet activity. Pregnant or breastfeeding individuals should use caution given insufficient safety data. People on anticoagulant, antiplatelet, or immunosuppressant therapies should consult a healthcare provider before use.